Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer Jun 09, 2009 Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis May 14, 2009 Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston May 12, 2009 Nektar Therapeutics Reports First Quarter 2009 Financial Results May 06, 2009 Nektar to Announce Financial Results for the First Quarter of 2009 on Wednesday, May 6, 2009, After Close of U.S.-Based Financial Markets Apr 29, 2009 NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR Apr 22, 2009 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston Mar 10, 2009 Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) Mar 02, 2009 Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results Feb 24, 2009 Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors Feb 17, 2009 Pagination First page « first Previous page ‹ previous … Page 40 Page 41 Page 42 Page 43 Current page 44 Page 45 Page 46 Page 47 Page 48 … Next page next › Last page last »